Invention Grant
- Patent Title: 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders
-
Application No.: US14759280Application Date: 2014-01-07
-
Publication No.: US09611229B2Publication Date: 2017-04-04
- Inventor: Antoni Torrens-Jover , Ute Christmann , Josè-Luis Diaz-Fernández , Carmen Almansa-Rosales
- Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
- Applicant Address: ES Barcelona
- Assignee: LABORATORIOS DEL DR. ESTEVE S.A.
- Current Assignee: LABORATORIOS DEL DR. ESTEVE S.A.
- Current Assignee Address: ES Barcelona
- Agency: Hueschen and Sage
- Priority: EP13382002 20130107
- International Application: PCT/EP2014/000012 WO 20140107
- International Announcement: WO2014/106622 WO 20140710
- Main IPC: C07D249/04
- IPC: C07D249/04 ; C07D249/06 ; C07D295/185 ; C07F7/10 ; C07D401/12
Abstract:
The present invention relates to new 1,2,3-triazole-amine derivatives, having affinity for sigma receptors, especially sigma-1 receptor, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments for the treatment of sigma receptor related diseases and disorders.
Public/Granted literature
- US20150353510A1 1,2,3-TRIAZOLE-4-AMINE DERIVATIVES FOR THE TREATMENT OF SIGMA RECEPTOR RELATED DISEASES AND DISORDERS Public/Granted day:2015-12-10
Information query
